Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in TNXP — Tonix Pharmaceuticals Holding Corp.

CIK 72971 SAN FRANCISCO, CA
Back to TNXP Full portfolio

Position in TNXP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$196,732
+$78,084 QoQ
Shares Held
15,418
+78.7% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 103 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TNXP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. TNXP ranks #252 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in TNXP

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $196,732 15,418
2026-03-31 $118,648 8,629
2025-12-31 $241,016 15,430
2025-09-30 $173,710 7,190
2025-06-30 $174,718 4,856
2024-12-31 $0 1
2024-09-30 $0 2
2024-03-31 $87 458
2023-12-31 $73 183
2023-09-30 $71 130
2023-06-30 $116 74
2023-03-31 $248 421
2022-12-31 $152 392
2022-09-30 $151 286
2022-06-30 $197 125
2022-03-31 $13,169 57,257
2021-12-31 $79,452 220,705
2021-09-30 $8,571 14,287
2021-06-30 $20,677 18,629
2021-03-31 $20,975 16,387
2020-12-31 $127,159 187,000
2020-09-30 $671 800
2020-06-30 $110 181
2020-03-31 $58 83